Medicare Part D – Page 26 – medicarereport.org

Friday, September 11, 2026

Latest:

Health Care Finance Part D/Prescription Drugs

Eileen Cook May 7, 2024May 7, 2024 Health Technology Assessments, Healthcare Costs, Healthcare Finance, Medicare Part D, Value-based drug pricing

The world is relying on the United States to get value-based drug pricing right

(By Jason Shafrin, Louis Garrison, and Melanie D. Whittington for ST A T) The changing landscape of drug pricing policy

Aging Alzheimer’s/Dementia Health Care Finance Health Insurance Medicare - General Medicare Advantage Nursing Homes Part D/Prescription Drugs Women’s Health

Eileen Cook May 2, 2024May 2, 2024 Alzheimer’s Disease, CMS, Dementia, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Older Adults, Women’s Health

10 Key Facts About Women with Medicare

(By Meredith Freed, Juliette Cubanski, Michelle Long, Nancy Ochieng, Tricia Neuman, and Alina Salganicoff for The Kaiser Family Foundation Published:

CMS Medicare - General Part D/Prescription Drugs

Eileen Cook April 29, 2024April 29, 2024 CMS, FDA, medicare, Medicare Part D, Older Adults, Reduce Heart Risk, Semaglutide, Wegovy

An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk

(By Chris Lee for The Kaiser Family Foundation published April 24, 2024) In a new analysis, KFF finds that 3.6

Aging CMS FDA Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook April 24, 2024April 24, 2024 CMS, FDA, Healthcare Costs, medicare, Medicare Advantage, Medicare Part D, Obesity, Older Adults, Ozempic, Wegovy

A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity

(By Juliette Cubanski, Tricia Neuman, Nolan Sroczynski, and Anthony Damico for The Kaiser Family Foundation Published: Apr 24, 2024) The

CMS Health Care Finance Health Insurance Medicare Advantage Pandemic

Eileen Cook April 17, 2024April 17, 2024 CMS, Healthcare Costs, Healthcare Finance, Medicare Advantage, Medicare Part D, pandemic

Medicare Advantage costs begin to stabilize, UnitedHealth says

(By Rylee Wilson for Becker’s Hospital Review ) Rising medical cost trends aren’t going down, but they are stabilizing, UnitedHealth

CMS Medicare - General Medicare Advantage Part D/Prescription Drugs Price Transparency Prior Authorization

Eileen Cook April 11, 2024April 11, 2024 CMS, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Price Transparency, Prior Authorization

Gaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency

(By Jeannie Fuglesten Biniek, Meredith Freed, and Tricia Neuman for The Kaiser Family Foundation Published: Apr 10, 2024) The Centers

Health Care Finance Part D/Prescription Drugs

Eileen Cook April 9, 2024April 9, 2024 Healthcare Finance, Medicare Part D, PBM Industry

Top PBMs by 2023 market share

(By Mackenzie Bean for Becker’s Hospital Review ) Three pharmacy benefit managers accounted for nearly 80% of all prescription claims

CMS Health Care - General Health Care Finance Health Care Redesign Health Insurance Medicare Advantage Part D/Prescription Drugs

Eileen Cook April 8, 2024April 8, 2024 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Older Adults

CMS finalizes 2025 Medicare Advantage rule: 11 key updates

(By Jakob Emerson for Becker’s Hospital Review ) CMS issued its final 2025 Medicare Advantage and Part D rule April

Health Care - General Health Care Finance Health Insurance Part D/Prescription Drugs Price Transparency

Arlene Sharp April 5, 2024April 5, 2024 Healthcare Costs, Insulin, medicare, Medicare Part D, Older Adults

Biden Is Right About $35 Insulin Cap but Exaggerates Prior Costs for Medicare Enrollees

By Samantha Putterman, Politifact for KFF Health News on April 5, 2024 The cost of insulin in the United States

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook April 4, 2024April 4, 2024 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Advantage Benchmark, Medicare Advantage Utilization, Medicare FFS cost trends, Medicare Part D

Why higher Medicare Advantage utilization wasn’t reflected in 2025 rates

(By Jakob Emerson for Becker’s Hospital Review ) CMS has finalized a slight decrease in Medicare Advantage benchmark payments for